Fibrosis, idiopathic pulmonary

Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, Bayne EK, DeMartino JA, MacIntyre DE, Forrest MJ (2003) Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci USA 100 7947-7952 Agostini C, Gurrieri C (2006) Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. Proc Am Thorac Soc 3 357-363... [Pg.213]

Cantin, A.M., North, S.L., Fells, G.A., Hubbard, R.C. and Crystal, R.G. (1987). Oxidant mediated epithelial cell injury in idiopathic pulmonary fibrosis. J. Clin. Invest. 79, 1665-1675. [Pg.228]

IP4 Inositol tetrakisphosphate IPF Idiopathic pulmonary fibrosis IPO Intestinal peroxidase IpOCOCq Isopropylidene OCOCq I/R Ischaemia-reperfusion IRAP IL-1 receptor antagonist protein IRF-1 Interferon regulatory factor 1 la Short-circuit current ISCOM Immune-stimulating complexes... [Pg.283]

Findings from studies of schistosomiasis-induced liver fibrosis, as well as other models of pulmonary, kidney, and liver fibrosis, strongly support the role of CD4+ Th2 cells in the progression of fibrosis (4). In this regard, analyses of gene and protein expression after stimulation by Thl (vs. Th2) cytokines indicates that IL-4 is found at increased concentrations in the bronchoalveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis, as well as in the peripheral blood mononuclear cells of those afflicted with periportal fibrosis (10,53-56). [Pg.303]

Gauldie J. Inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002 165(9) 1205-1206. [Pg.311]

Harari S, Caminati A. Idiopathic pulmonary fibrosis. Allergy 2005 60(4) 421 435. [Pg.312]

Abdelaziz MM, Samman YS, Wali SO, Hamad MM. Treatment of idiopathic pulmonary fibrosis is there anything new Respirology 2005 10(3) 284-289. [Pg.316]

Gharaee-Kermani M, Phan SH. Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis. Curr Pharm Des 2005 11(30) 3943-3971. [Pg.316]

Iyonaga K, Takeya M, Saita N, et al. Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases. Hum Pathol 1994 25(5) 455-463. [Pg.316]

Kitasato Y, Hoshino T, Okamoto M, et al. Enhanced expression of interleukin-18 and its receptor in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol... [Pg.317]

Capelli A, Di Stefano A, Gnemmi I, Donner CF. CCR5 expression and CC che-mokine levels in idiopathic pulmonary fibrosis. Eur Respir J 2005 25(4) 701-707. [Pg.318]

Selman M, Thannickal VJ, Pardo A, Zisman DA, Martinez FJ, Lynch JP, 3rd. Idiopathic pulmonary fibrosis pathogenesis and therapeutic approaches. Drugs 2004 64(4) 405-430. [Pg.318]

Raghu, G. et al., A placebo-controlled trial of interferon gamma-lb in patients with idiopathic pulmonary fibrosis, N. Engl. J Med, 350, 125, 2004. [Pg.167]

It regulates mucus production, inflammation, fibrosis and tissue remodeling. IL-13 is a therapeutic target for a number of disease states including asthma, idiopathic pulmonary fibrosis, ulcerative colitis, cancer and others. Its signaling is mediated via IL-4 type 2 receptor. The receptor consists of IL-4Ra and IL-13Ral and IL-13Ra2 chains. [Pg.42]

Cutaneous alternariosis (infection with Alternaria alter-nata) has been described in a 78-year-old farmer with idiopathic pulmonary fibrosis taking oral prednisone 20 mg/day (341). [Pg.39]

Ioannidou DJ, Stefanidou MP, Maraki SG, Panayiotides JG, Tosca AD. Cutaneous alternariosis in a patient with idiopathic pulmonary fibrosis. Int J Dermatol 2000 39(4) 293-5. [Pg.65]

Mariotta S, Pallone G, Li Bianchi E, Gilardi G, Bisetti A. Strongyloides stercoralis hyperinfection in a case of idiopathic pulmonary fibrosis. Panminerva Med 1996 38(l) 45-7. [Pg.65]

Theoretically, a number of other diseases affecting the pulmonary interstitium might be treated with gene therapy. These include interstitial pneumonitides and idiopathic pulmonary fibrosis. These approaches will depend upon further advancements in the study of the basic pathobiology of these disorders. [Pg.87]

A 60-year-old woman with bipolar disorder since the age of 29 developed idiopathic pulmonary fibrosis (cryptogenic fibrosing alveolitis) after having taken lithium for 9 years (148). Whether lithium played a causal role is at best highly speculative. [Pg.133]

Bhandari S, Samellas D. Bipolar affective disorder and idiopathic pulmonary fibrosis. J Clin Psychiatry 2001 62(7) 574-5. [Pg.168]

Gaensler EA, Jederlinic PJ, Churg A. 1991. Idiopathic pulmonary fibrosis in asbestos-exposed workers. Am Rev Respir Dis 144(3) 689-696. [Pg.267]

Zhang Y, Lee TC, Guillemin B, et al. 1993. Enhanced IL-lbeta tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol 150 4188-4196. [Pg.345]

Jonard, R, Geubel, A., Wallon, J., Rahier, J., Dive, C., Meunier, H. Primary sclerosing cholangitis and idiopathic pulmonary fibrosis a case report. Acta Clin. Belg. 1989 44 24-30... [Pg.673]

See also in sourсe #XX -- [ Pg.304 , Pg.308 ]

See also in sourсe #XX -- [ Pg.209 ]

See also in sourсe #XX -- [ Pg.179 ]

See also in sourсe #XX -- [ Pg.453 ]

See also in sourсe #XX -- [ Pg.204 ]

See also in sourсe #XX -- [ Pg.201 , Pg.202 ]

See also in sourсe #XX -- [ Pg.275 ]

See also in sourсe #XX -- [ Pg.339 ]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...